Search Results 421-430 of 18070 for insulin response

  1. Thiothixene (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. ... Insulin Aspart, Recombinant ...

  2. Teriparatide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if ...

  3. Testosterone (intramuscular route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. ... Insulin; Insulin Aspart, Recombinant; Insulin ...

  4. Secondary hypertension - Symptoms & causes - Mayo Clinic

    Hyperparathyroidism. The parathyroid glands control levels of calcium and phosphorus in the body. If the glands release too much parathyroid hormone, the amount ...

  5. Torsemide (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if ...

  6. General Internal Medicine - Clinical trials

    This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical ...

  7. A Study to Evaluate Direct Measurement of Proinsulin Clearance in Humans - Mayo Clinic

    The purpose of this study is to determine if changes in fasting glucose and FFA concentrations alter 1st phase insulin secretion and proinsulin secretion in ...

  8. Nutrition Obesity Research Program

    Other goals are to clarify mitochondrial action that favors fat storage versus use, understand cellular pathways related to insulin ... response. This ...

  9. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    ... response rate (BORR) of combined ramucirumab (RAM) plus paclitaxel (+/- pembrolizumab) following induction pembrolizumab (PEM) in patients with advanced ...

  10. Neoadjuvant Aliya™ PEF Soft Tissue Ablation With Systemic Therapy in Early-Stage Resectable NSCLC (VIGOR) - Mayo Clinic

    The purpose of this study is to evaluate the pathologic response ... response. Patient requires or ... Replacement therapy (e.g., thyroxine, insulin, or ...